Associated Papers
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies.
Flümann R et al.
Blood Cancer Discovery, 2023
36346827 (PubMed )
Supplement: bcd-22-0007_table_s6_suppst6.xlsx › F_Mut_Pat.__6
Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis.
Zhang W et al.
Orphanet Journal of Rare Diseases, 2022
35668470 (PubMed )
Supplement: 13023_2022_2349_MOESM5_ESM.xlsx › ________
De novo mutations in moderate or severe intellectual disability.
Hamdan FF et al.
Plos Genetics, 2014
25356899 (PubMed )
Supplement: pgen.1004772.s004.xlsx › 580.240
Select a paper to view details